BMY has been in the news 357% more than usual
May 13, 2025, 2:34 PM
6.47%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: President Trump announced plans for an executive order aimed at reducing prescription drug prices in the U.S., which influenced the pharmaceutical market positively. Meanwhile, Merck's shares rose 5% as the executive order's impact was less severe than anticipated, benefiting pharmaceutical stocks, including Bristol-Myers Squibb Company.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.